ProteoNic Unveils Early Access Program, Elevating Viral Vector Titers with Transformative LV-2G UNic® Technology
March 27th, 2024 10:00 CET
ProteoNic Biosciences , a leading provider of premium vector technology and services for the production of biologics, is announcing the launch of its highly anticipated...